loading

Finanzdaten der Mineralys Therapeutics Inc-Aktie (MLYS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
442.66%
246.04
45.34 38.28 41.13 46.75
Operating Income/Loss
442.66%
-246.04
-45.34 -38.28 -41.13 -46.75
Nonoperating Income/Loss
17.20%
4.969
6.001 6.046 4.199 3.472
Net Income/Loss
512.80%
-241.07
-39.34 -32.23 -36.93 -43.27
Basic Average Shares
2.28%
84.73
82.83 - 70.59 65.45
Diluted Average Shares
2.28%
84.73
82.83 - 70.59 65.45
Basic Earnings Per Share
506.38%
-2.85
-0.47 - -0.52 -0.66
Diluted Earnings Per Share
506.38%
-2.85
-0.47 - -0.52 -0.66
$17.10
price down icon 3.88%
$120.30
price down icon 5.53%
$11.26
price down icon 12.17%
$3.465
price down icon 16.71%
$13.28
price down icon 4.80%
$31.32
price down icon 3.09%
Kapitalisierung:     |  Volumen (24h):